Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,164 | 207 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $839.52 | 26 | $0 (2024) |
| ABBVIE INC. | $681.99 | 52 | $0 (2024) |
| GlaxoSmithKline, LLC. | $343.50 | 13 | $0 (2024) |
| PFIZER INC. | $340.66 | 23 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $269.17 | 4 | $0 (2024) |
| Novo Nordisk Inc | $251.86 | 23 | $0 (2024) |
| Xeris Pharmaceuticals, Inc. | $177.13 | 9 | $0 (2024) |
| Astellas Pharma US Inc | $171.48 | 7 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $118.13 | 4 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $110.47 | 5 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,421 | 77 | ABBVIE INC. ($224.08) |
| 2023 | $1,556 | 88 | AstraZeneca Pharmaceuticals LP ($382.20) |
| 2022 | $930.76 | 38 | AstraZeneca Pharmaceuticals LP ($247.29) |
| 2021 | $256.92 | 4 | Otsuka America Pharmaceutical, Inc. ($115.69) |
All Payment Transactions
207 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Chiesi USA, Inc. | MYCAPSSA (Drug) | Food and Beverage | Cash or cash equivalent | $19.59 | General |
| Category: ACROMEGALY | ||||||
| 12/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: Diabetes | ||||||
| 12/12/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $12.62 | General |
| Category: PAIN | ||||||
| 12/05/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $6.16 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $15.00 | General |
| Category: PSYCHIATRY | ||||||
| 11/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: Diabetes | ||||||
| 11/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.04 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $21.05 | General |
| Category: PAIN | ||||||
| 11/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: RESPIRATORY | ||||||
| 11/07/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $7.50 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $27.10 | General |
| Category: DIABETES | ||||||
| 10/17/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $10.17 | General |
| Category: NEUROSCIENCE | ||||||
| 10/10/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: HIV | ||||||
| 10/08/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $8.86 | General |
| Category: NEUROSCIENCE | ||||||
| 10/04/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $36.21 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/03/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $15.20 | General |
| 09/27/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $22.95 | General |
| 09/25/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: Biological | ||||||
| 09/25/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $13.42 | General |
| Category: PSYCHIATRY | ||||||
| 09/18/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $32.19 | General |
| Category: HIV | ||||||
| 09/12/2024 | Alnylam Pharmaceuticals Inc. | OXLUMO (Drug) | Food and Beverage | In-kind items and services | $22.36 | General |
| Category: Genetic Disease | ||||||
| 09/11/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $23.01 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 08/27/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Diabetes | ||||||
| 08/22/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $24.92 | General |
| Category: Biological | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 2 | 73 | 73 | $16,206 | $4,736 |
| 2021 | 5 | 245 | 257 | $39,470 | $13,628 |
| 2020 | 4 | 194 | 217 | $26,624 | $7,810 |
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 43 | 43 | $10,836 | $3,205 | 29.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 30 | 30 | $5,370 | $1,531 | 28.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 47 | 48 | $12,096 | $4,670 | 38.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 63 | 65 | $11,497 | $4,048 | 35.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 78 | 87 | $10,062 | $3,087 | 30.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 13 | 13 | $3,219 | $1,110 | 34.5% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 44 | 44 | $2,596 | $713.04 | 27.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 80 | 97 | $11,349 | $3,426 | 30.2% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 33 | 35 | $8,820 | $2,584 | 29.3% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 69 | 73 | $4,307 | $1,179 | 27.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 12 | 12 | $2,148 | $620.88 | 28.9% |
About Frances Hull
Frances Hull is a Registered Nurse healthcare provider based in Yakima, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/20/2015. The National Provider Identifier (NPI) number assigned to this provider is 1336531870.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Frances Hull has received a total of $4,164 in payments from pharmaceutical and medical device companies, with $1,421 received in 2024. These payments were reported across 207 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($4,164).
As a Medicare-enrolled provider, Hull has provided services to 512 Medicare beneficiaries, totaling 547 services with total Medicare billing of $26,174. Data is available for 3 years (2020–2022), covering 11 distinct procedure/service records.
Practice Information
- Specialty Registered Nurse
- Other Specialties Family
- Location Yakima, WA
- Active Since 02/20/2015
- Last Updated 01/17/2020
- Taxonomy Code 163W00000X
- Entity Type Individual
- NPI Number 1336531870
Products in Payments
- FARXIGA (Drug) $488.38
- REXULTI (Drug) $338.14
- QULIPTA (Drug) $284.31
- NURTEC ODT (Drug) $283.47
- UBRELVY (Drug) $222.46
- SHINGRIX (Biological) $176.57
- Veozah (Drug) $171.48
- GEMTESA (Drug) $169.38
- GVOKE HYPOPEN (Drug) $159.95
- TRELEGY ELLIPTA (Drug) $142.22
- Ozempic (Drug) $135.10
- VRAYLAR (Drug) $131.50
- Rybelsus (Drug) $109.90
- INGREZZA (Drug) $102.85
- JARDIANCE (Drug) $88.39
- SOLIQUA 100/33 (Biological) $57.77
- PAXLOVID (Drug) $57.19
- APRETUDE (Biological) $45.74
- LEQVIO (Drug) $37.63
- ENTYVIO (Biological) $36.21
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Registered Nurse Doctors in Yakima
Melanie Adams, Rn60262073, Ap613156, RN60262073, AP613156
Registered Nurse — Payments: $5,158
Homira Feely, Msn, Arnp, MSN, ARNP
Registered Nurse — Payments: $894.98
Shannon Bolt, Arnp, ARNP
Registered Nurse — Payments: $578.62
Julie Wells, Arnp, ARNP
Registered Nurse — Payments: $315.63
Leslie Smith, Arnp, Bsn, Bs, Rn, ARNP, BSN, BS, RN
Registered Nurse — Payments: $308.39
Nina Reiss, Rn, RN
Registered Nurse — Payments: $262.46